Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,421 public trials 1,317 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

NCT01732848

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Local Institution Los Angeles, California, United States
  • Prism Research Saint Paul, Minnesota, United States
  • New Orleans Center For Clinical Research - Knoxville Knoxville, Tennessee, United States
  • Local Institution San Antonio, Texas, United States
View Trial Details
Completed

A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

NCT00627926

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Birmingham, Alabama, United States
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Fresno, California, United States
View all 116 locations
View Trial Details
Completed

A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)

NCT00420784

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Birmingham Gastroenterology Associates Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • USC Los Angeles, California, United States
  • Kaiser Permanente Hepatology Research San Diego, California, United States
View all 53 locations
View Trial Details
Completed

A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy

NCT00535847

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Kaiser Permanente Internal Medicine San Diego, California, United States
  • San Francisco, California, United States
View all 62 locations
View Trial Details
Completed

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

NCT00539383

Conditions
Adenocarcinoma, Advanced Solid Tumors With and Without Brain Metastases, Brain Diseases, +31 more
Locations
  • Gabrail Cancer Center Canton, Ohio, United States
  • University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • UT Health Science Center, Cancer Therapy and Research Center San Antonio, Texas, United States
View Trial Details

Related conditions